Seilern Investment Management Ltd Sells 2,214 Shares of CME Group Inc. $CME

Key Points

• Seilern Investment Management Ltd reduced its stake in CME Group Inc. by 7.5%, selling 2,214 shares and now holding 27,310 shares valued at $7,527,000.
• Institutional investors own approximately 87.75% of CME Group's stock, highlighting significant institutional interest in the company.
• CME Group recently announced a quarterly dividend of $1.25, with a 1.9% dividend yield, payable on September 25th.

Seilern Investment Management Ltd lessened its position in shares of CME Group Inc. (NASDAQ:CME - Free Report) by 7.5% during the second quarter, according to its most recent filing with the Securities and Exchange Commission. The firm owned 27,310 shares of the financial services provider's stock after selling 2,214 shares during the period. CME Group makes up about 0.5% of Seilern Investment Management Ltd's holdings, making the stock its 21st biggest position. Seilern Investment Management Ltd's holdings in CME Group were worth $7,527,000 at the end of the most recent reporting period.

Other hedge funds and other institutional investors have also bought and sold shares of the company. Vanguard Group Inc. grew its stake in CME Group by 1.2% in the 1st quarter. Vanguard Group Inc. now owns 34,643,827 shares of the financial services provider's stock worth $9,190,661,000 after buying an additional 400,737 shares in the last quarter. Raymond James Financial Inc. grew its stake in CME Group by 9.7% in the 1st quarter. Raymond James Financial Inc. now owns 4,113,991 shares of the financial services provider's stock worth $1,091,401,000 after buying an additional 363,130 shares in the last quarter. Massachusetts Financial Services Co. MA grew its stake in CME Group by 29.9% in the 1st quarter. Massachusetts Financial Services Co. MA now owns 2,818,590 shares of the financial services provider's stock worth $747,744,000 after buying an additional 648,591 shares in the last quarter. AQR Capital Management LLC grew its stake in CME Group by 10.3% in the 1st quarter. AQR Capital Management LLC now owns 2,783,759 shares of the financial services provider's stock worth $735,539,000 after buying an additional 260,065 shares in the last quarter. Finally, UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC grew its stake in CME Group by 11.9% in the 1st quarter. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC now owns 2,727,809 shares of the financial services provider's stock worth $723,660,000 after buying an additional 290,147 shares in the last quarter. Institutional investors own 87.75% of the company's stock.

Insider Activity

In other CME Group news, Director William R. Shepard purchased 256 shares of the firm's stock in a transaction that occurred on Wednesday, June 25th. The stock was bought at an average cost of $270.53 per share, for a total transaction of $69,255.68. Following the purchase, the director directly owned 258,196 shares in the company, valued at $69,849,763.88. The trade was a 0.10% increase in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, insider Sunil Cutinho sold 11,896 shares of the stock in a transaction dated Tuesday, August 26th. The stock was sold at an average price of $271.47, for a total transaction of $3,229,407.12. Following the completion of the transaction, the insider owned 17,440 shares of the company's stock, valued at approximately $4,734,436.80. The trade was a 40.55% decrease in their ownership of the stock. The disclosure for this sale can be found here. Company insiders own 0.30% of the company's stock.

CME Group Trading Down 0.0%

Shares of CME opened at $262.30 on Friday. The stock has a market capitalization of $94.53 billion, a P/E ratio of 25.39, a PEG ratio of 4.75 and a beta of 0.43. The company has a quick ratio of 1.02, a current ratio of 1.02 and a debt-to-equity ratio of 0.12. The firm has a fifty day simple moving average of $273.60 and a two-hundred day simple moving average of $270.45. CME Group Inc. has a twelve month low of $212.38 and a twelve month high of $290.79.

CME Group (NASDAQ:CME - Get Free Report) last announced its quarterly earnings results on Wednesday, July 23rd. The financial services provider reported $2.96 earnings per share for the quarter, beating the consensus estimate of $2.91 by $0.05. The business had revenue of $1.69 billion during the quarter, compared to analysts' expectations of $1.68 billion. CME Group had a net margin of 58.48% and a return on equity of 14.60%. The firm's revenue for the quarter was up 10.4% compared to the same quarter last year. During the same quarter in the prior year, the company posted $2.56 EPS. On average, research analysts anticipate that CME Group Inc. will post 10.49 EPS for the current year.

CME Group Announces Dividend

The business also recently announced a quarterly dividend, which will be paid on Thursday, September 25th. Stockholders of record on Tuesday, September 9th will be given a $1.25 dividend. This represents a $5.00 annualized dividend and a dividend yield of 1.9%. The ex-dividend date of this dividend is Tuesday, September 9th. CME Group's dividend payout ratio (DPR) is currently 48.40%.

Analyst Ratings Changes

A number of research firms have commented on CME. Piper Sandler boosted their price target on shares of CME Group from $283.00 to $296.00 and gave the stock an "overweight" rating in a research note on Tuesday, July 15th. Oppenheimer boosted their price target on shares of CME Group from $300.00 to $303.00 and gave the stock an "outperform" rating in a research note on Thursday, July 24th. Barclays set a $298.00 price objective on shares of CME Group and gave the company an "equal weight" rating in a research note on Thursday, July 24th. Erste Group Bank cut shares of CME Group from a "strong-buy" rating to a "hold" rating in a research note on Saturday, May 24th. Finally, Citigroup upped their price objective on shares of CME Group from $265.00 to $275.00 and gave the company a "neutral" rating in a research note on Thursday, July 3rd. Four equities research analysts have rated the stock with a Buy rating, nine have given a Hold rating and three have given a Sell rating to the company's stock. According to MarketBeat.com, the stock has an average rating of "Hold" and a consensus price target of $260.60.

CME Group Company Profile

CME Group Inc, together with its subsidiaries, operates contract markets for the trading of futures and options on futures contracts worldwide. It offers futures and options products based on interest rates, equity indexes, foreign exchange, agricultural commodities, energy, and metals, as well as fixed income and foreign currency trading services.

Want to see what other hedge funds are holding CME? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for CME Group Inc. (NASDAQ:CME - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.